Clinical Trial Update: Evaluation of the Efficacy and Safety of MV140 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety of MV140 for bacterial urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• MV140

Snippet

Sponsor: Inmunotek S.L. | Conditions: Urinary Tract Infection Bacterial | Phase 3 | Status: COMPLETED